MCC/HA (Bioniche)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameMCC/HA (Bioniche)
Drug Alias Namemycobacterial cell wall-DNA complex/hyaluronic acid (Bioniche)
ClassificationSmall molecules
Mechanisms of ActionApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTelesta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTelesta Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A